CK Life Sciences

CK Life Sciences International (Holdings) Inc.
長江生命科技集團有限公司
Listed company
Industry Biotechnology
Founded 2000
Headquarters Hong Kong
Area served
 Hong Kong
Key people
 Chairman: Mr. Victor Li
Parent Cheung Kong Holdings
Website CK Life Sciences International (Holdings) Inc.

CK Life Sciences International (Holdings) Inc. (Chinese: 長江生命科技集團有限公司) (SEHK: 775), or CK Life Sciences, is the subsidiary of Cheung Kong Holdings in Hong Kong. It is engaged in the business of research and development, commercialization, marketing and sale of biotechnology products.[1] The chairman is Mr. Victor Li, the elder son of Mr. Li Ka-shing, the chairman of Cheung Kong Holdings.

It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002 (Former stock code: SEHK: 8222).[2][3] It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.[4][5]

References

  1. ↑ CK Life Sciences International Holdings Inc.
  2. ↑ CK Life Sciences Bestowed Outstanding Biochemistry Technology Company Award by Capital Magazine
  3. ↑ CK Life To Raise HK $2.93 Bn Via IPO
  4. ↑ Li Ka-shing, Li Tzar-kuoi raise stake in CK Life Sciences
  5. ↑ Transfer of Listing from GEM to Main Board

External links

This article is issued from Wikipedia - version of the 2/23/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.